Continuing Care App for Probationers and Parolees with Substance Use Disorders

适用于患有药物滥用障碍的缓刑犯和假释犯的持续护理应用程序

基本信息

  • 批准号:
    8997778
  • 负责人:
  • 金额:
    $ 16.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-28 至 2017-12-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Substance use disorders (SUDs) continue to be one of the most serious public health problems in the US. Studies have consistently documented a substantially higher prevalence of SUDs among individuals under criminal justice supervision. At year-end 2013, approximately 4.75 million adults were on probation or parole (1 in 51 adults). African American probationers and parolees with SUDs are particularly vulnerable to illicit substance use and HIV infection as they typically live in neighborhoods characterized by high rates of joblessness, drug use, and poverty and they are likely to engage in drug-and sex-related HIV risk behaviors in the community. Studies have shown that continuing care interventions have been found to extend primary treatment gains with respect to reductions in substance use, relapse, and criminal activity. We propose to develop a continuing care mobile application for probationers and parolees completing substance abuse treatment who are at high risk of substance abuse relapse, HIV related risk factors, and re-arrest and re- incarceration. Probationers and parolees, many of whom are low-income urban African Americans, are an important health disparity population that stands to benefit from continuing care technologies. This research will be conducted in collaboration with Total Health Care (THC), a federally qualified health center and Maryland's largest minority-operated non-profit community health center. If found effective, the proposed application could be deployed across the national network of outpatient substance abuse treatment providers/programs, potentially improving the dissemination of continuing care services outside of traditional systems of care and be highly significant in its direct impact on public health for individuals involved in the criminal justice system.
 描述(由申请人提供):物质使用障碍(SUD)仍然是美国最严重的公共卫生问题之一。研究一致记录了刑事司法监督下的个体中SUD的患病率显著较高。截至2013年底,约有475万成年人处于缓刑或假释期(每51名成年人中就有1名)。非裔美国人缓刑犯和假释与SUD特别容易受到非法药物使用和艾滋病毒感染,因为他们通常生活在以高失业率,吸毒和贫困为特征的社区,他们很可能在社区从事与毒品和性有关的艾滋病毒风险行为。研究表明,已发现持续护理干预措施在减少药物使用、复发和犯罪活动方面扩大了初级治疗的收益。我们建议为完成药物滥用治疗的受感化者和假释犯开发一个持续护理移动的应用程序,这些受感化者和假释犯具有药物滥用复发、艾滋病毒相关风险因素以及重新被捕和重新监禁的高风险。缓刑犯和假释犯,其中许多是低收入的城市非洲裔美国人,是一个重要的健康差距人口,将受益于持续的护理技术。这项研究将与全面保健(THC),一个联邦合格的健康中心和马里兰州最大的少数民族经营的非营利社区健康中心合作进行。如果发现有效,拟议的应用程序可以部署在全国网络的门诊药物滥用治疗提供者/方案,有可能改善传播的持续护理服务以外的传统护理系统,并在其对公共卫生的直接影响是非常显着的个人参与刑事司法系统。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Scott Gordon其他文献

Michael Scott Gordon的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael Scott Gordon', 18)}}的其他基金

Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment
长效纳曲酮用于释放前囚犯:流动治疗的随机试验
  • 批准号:
    10738933
  • 财政年份:
    2023
  • 资助金额:
    $ 16.99万
  • 项目类别:
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
缓释纳曲酮与缓释丁丙诺啡对出狱人员的效果比较试验
  • 批准号:
    10160255
  • 财政年份:
    2019
  • 资助金额:
    $ 16.99万
  • 项目类别:
A comparison of Sublingual and Extended-Release Buprenorphine for Individuals Leaving Jail
舌下含服和缓释丁丙诺啡对出狱人员的比较
  • 批准号:
    10547922
  • 财政年份:
    2019
  • 资助金额:
    $ 16.99万
  • 项目类别:
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
缓释纳曲酮与缓释丁丙诺啡对出狱人员的效果比较试验
  • 批准号:
    10616501
  • 财政年份:
    2019
  • 资助金额:
    $ 16.99万
  • 项目类别:
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
缓释纳曲酮与缓释丁丙诺啡对出狱人员的效果比较试验
  • 批准号:
    9978020
  • 财政年份:
    2019
  • 资助金额:
    $ 16.99万
  • 项目类别:
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
缓释纳曲酮与缓释丁丙诺啡对出狱人员的效果比较试验
  • 批准号:
    10388285
  • 财政年份:
    2019
  • 资助金额:
    $ 16.99万
  • 项目类别:
Buprenorphine for probationers and parolees: Bridging the gap into treatment
丁丙诺啡用于缓刑犯和假释犯:缩小治疗差距
  • 批准号:
    9898338
  • 财政年份:
    2018
  • 资助金额:
    $ 16.99万
  • 项目类别:
Buprenorphine for probationers and parolees: Bridging the gap into treatment
丁丙诺啡用于缓刑犯和假释犯:缩小治疗差距
  • 批准号:
    10610309
  • 财政年份:
    2018
  • 资助金额:
    $ 16.99万
  • 项目类别:
Buprenorphine for probationers and parolees: Bridging the gap into treatment
丁丙诺啡用于缓刑犯和假释犯:缩小治疗差距
  • 批准号:
    9900629
  • 财政年份:
    2018
  • 资助金额:
    $ 16.99万
  • 项目类别:
Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment
长效纳曲酮用于释放前囚犯:流动治疗的随机试验
  • 批准号:
    9689961
  • 财政年份:
    2016
  • 资助金额:
    $ 16.99万
  • 项目类别:

相似海外基金

Neurobiological impact of acute digital media abstinence among drug using college students
吸毒大学生急性数字媒体戒断的神经生物学影响
  • 批准号:
    10677380
  • 财政年份:
    2023
  • 资助金额:
    $ 16.99万
  • 项目类别:
Effects of Acute Combination Pharmacotherapy on Morning Smoking Abstinence Symptoms in Female Smokers
急性联合药物治疗对女性吸烟者晨间戒烟症状的影响
  • 批准号:
    191742
  • 财政年份:
    2009
  • 资助金额:
    $ 16.99万
  • 项目类别:
    Operating Grants
ACUTE NICOTINE ABSTINENCE IN ADOLESCENTS
青少年的急性尼古丁戒断
  • 批准号:
    2859316
  • 财政年份:
    1998
  • 资助金额:
    $ 16.99万
  • 项目类别:
ACUTE NICOTINE ABSTINENCE IN ADOLESCENTS
青少年的急性尼古丁戒断
  • 批准号:
    6182973
  • 财政年份:
    1998
  • 资助金额:
    $ 16.99万
  • 项目类别:
ACUTE NICOTINE ABSTINENCE IN ADOLESCENTS
青少年的急性尼古丁戒断
  • 批准号:
    6388102
  • 财政年份:
    1998
  • 资助金额:
    $ 16.99万
  • 项目类别:
ACUTE NICOTINE ABSTINENCE IN ADOLESCENTS
青少年的急性尼古丁戒断
  • 批准号:
    2889591
  • 财政年份:
    1998
  • 资助金额:
    $ 16.99万
  • 项目类别:
Menstrual Phase and Depression Symptoms in Acute Smoking Abstinence
月经期和急性戒烟时的抑郁症状
  • 批准号:
    7209380
  • 财政年份:
    1993
  • 资助金额:
    $ 16.99万
  • 项目类别:
Menstrual Phase and Depression Symptoms in Acute Smoking Abstinence
月经期和急性戒烟时的抑郁症状
  • 批准号:
    7597199
  • 财政年份:
    1993
  • 资助金额:
    $ 16.99万
  • 项目类别:
Menstrual Phase and Depression Symptoms in Acute Smoking Abstinence
月经期和急性戒烟时的抑郁症状
  • 批准号:
    7813791
  • 财政年份:
    1993
  • 资助金额:
    $ 16.99万
  • 项目类别:
ACUTE ABSTINENCE FROM TOBACCO--ELECTROPHYSIOLOGICAL AND COGNITIVE SIGNS
急性戒烟——电生理和认知体征
  • 批准号:
    3853769
  • 财政年份:
  • 资助金额:
    $ 16.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了